Literature DB >> 8018207

Tumour antigens. A new look for the 1990s.

D M Pardoll.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8018207     DOI： 10.1038/369357a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  33 in total

Review 1.  The next wave of recombinant and synthetic anticancer vaccines.

Authors:  K R Irvine; N P Restifo
Journal:  Semin Cancer Biol       Date:  1995-12       Impact factor: 15.707

Review 2.  The new vaccines: building viruses that elicit antitumor immunity.

Authors:  N P Restifo
Journal:  Curr Opin Immunol       Date:  1996-10       Impact factor: 7.486

Review 3.  Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions.

Authors:  R G Vile; H Chong
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

4.  Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100.

Authors:  Y Zhai; J C Yang; P Spiess; M I Nishimura; W W Overwijk; B Roberts; N P Restifo; S A Rosenberg
Journal:  J Immunother       Date:  1997-01       Impact factor: 4.456

5.  Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen.

Authors:  M Wang; P W Chen; V Bronte; S A Rosenberg; N P Restifo
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1995-10

6.  Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma.

Authors:  W J Bateman; I Donnellan; I A Fraser; L S Wong; A G Morris
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

7.  Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity.

Authors:  J L Schultze; A A Cardoso; G J Freeman; M J Seamon; J Daley; G S Pinkus; J G Gribben; L M Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

8.  Presentation of synthetic peptide antigen encoded by the MAGE-1 gene by granulocyte/macrophage-colony-stimulating-factor-cultured macrophages from HLA-A1 melanoma patients.

Authors:  S Yamasaki; T Okino; N G Chakraborty; W O Adkisson; A Sampieri; S J Padula; F Mauri; B Mukherji
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

Review 9.  Vaccine therapy for cancer.

Authors:  D C Linehan; P S Goedegebuure; T J Eberlein
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

Review 10.  IL-2 gene therapy of solid tumors: an approach for the prevention of signal transduction defects in T cells.

Authors:  K S Zier; B Gansbacher
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.